Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v5-EN Version v1-EN
Language English English
Date Updated 2019-08-30 2019-01-15
Drug Identification Number 02443376 02443376
Brand name KETOROLAC TROMETHAMINE INJECTION, USP KETOROLAC TROMETHAMINE INJECTION, USP
Common or Proper name Ketorolac Ketorolac
Company Name JUNO PHARMACEUTICALS CORP. JUNO PHARMACEUTICALS CORP.
Ingredients KETOROLAC TROMETHAMINE KETOROLAC TROMETHAMINE
Strength(s) 30MG 30MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAMUSCULAR INTRAMUSCULAR
Packaging size Carton 10 Vials Carton 10 Vials
ATC code M01AB M01AB
ATC description ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date 2019-09-03 2019-01-15
Actual start date 2019-09-03 2019-01-15
Estimated end date 2019-10-04 2019-01-31
Actual end date
Shortage status Anticipated shortage Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments